medigraphic.com

2011, Number 1

<< Back Next >>

Med Sur 2011; 18 (1)

Miocarditis aguda

Millán-Iturbe O, Padilla-Quiroz P, Michel-Ortega RM, Ramírez-González L, Osornio-García I, Herrera-Bello H, Mendoza-Díaz PM, Rivera-Figueroa J, Bucio-Reta E, García-López S, González-Chon O

Language: Spanish
References: 24
Page: 14-17
PDF size: 128.84 Kb.


ABSTRACT

Myocarditis is an inflammatory myocardial disease whose etiology can be variable. Clinical presentation range from asymptomatic or signs of a virical infection, to symptoms of acute cardiac failure or fulminant hemodynamic collapse with sudden death. Diagnosis is made by clinical presentation and complementary studies, but confirmation diagnosis is made by endomyocardial biopsy.


REFERENCES

  1. Smith WG. Adult heart disease due Coxsackie virus group B. Br Heart J 1966; 28: 204-20.

  2. Firman G. The incidence and epidemiology of myocarditis. Eur Heart J 1999; 20: 1063-5.

  3. Peters N, et al. Myocarditis continuing clinical and pathologic confusion. Am Heart J 1991; 121: 942-7.

  4. Gravanis MG, Sternby NH. Incidence of myocarditis. Arch Pathol Lab Med 1991; 15: 390–2.

  5. Bowles NE, Ni J, Kearney DL, et al. Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 2003; 42: 466.

  6. Chen F, Shannon K, Ding S, et al. HIV type 1 glycoprotein 120 inhibits cardiac myocyte contraction. AIDS Res Hum Retroviruses 2002; 18: 777-84.

  7. Rassi A Jr, Rassi A, Little WC, et al. Development and validation of a risk score for predicting death in Chagas’ heart disease. N Engl J Med 2006; 355: 799-808.

  8. Daniels P, Tazelaar H, Edwards W, Cooper L. Giant cell myocarditis as a manifestation of drug hypersensitivity. Cardiovasc Pathol 2000; 9: 287-91.

  9. Corssmit EP, Trip MD, Durrer JD. Löffler’s endomyocarditis in the idiopathic hypereosinophilic syndrome. Cardiol 1999; 91: 272-6.

  10. Dec GW Jr, Palacios IF, Fallon JT, et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies: clinical features, histologic correlates, and clinical outcome. N Engl J Med 1985; 312: 885-90.

  11. Feldman AM, McNamara D. Myocarditis N Engl J Med 2001; 344: 1388-98.

  12. Cooper L Jr. Myocarditis. N Eng J Med 2009; 360: 1526-38.

  13. Lauer B, Niederau C, Kühl U, et al. Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol 1997; 30: 1354-9.

  14. Sheppard R, Bedi M, Kubota T, et al. Myocardial expression of fas and recovery of left ventricular function in patients with recentonset cardiomyopathy. J AmColl Cardiol 2005; 46: 1036-42.

  15. Nishii M, Inomata T, Takehana H, et al. Serum levels of interleukin-10 on admission as a prognostic predictor of human fulminant myocarditis. J Am Coll Cardiol 2004; 44: 1292-7.

  16. Vignola PA, Aonuma K, Swaye PS, et al. Lymphocytic myocarditis presenting as unexplained ventricular arrhythmias: diagnosis with endomyocardial biopsy and response to immunosuppression. J Am Coll Cardiol 1984; 4: 812-9.

  17. Skouri HN, Dec GW, Friedrich MG, Cooper LT. Noninvasive imaging in myocarditis. J Am Coll Cardiol 2006; 48: 2085-93.

  18. Dec GW Jr, Waldman H, Southern J, Fallon JT, Hutter AM Jr, Palacios I. Viral myocarditis mimicking acute myocardial infarction. J Am Coll Cardiol 1992; 20: 85-9.

  19. Chen YS, Yu HY. Choice of mechanical support for fulminant myocarditis: ECMO vs. VAD? Eur J Cardiothorac Surg 2005; 27: 931-2.

  20. Topkara VK, Dang NC, Barili F, et al. Ventricular assist device use for the treatment of acute viral myocarditis. J Thorac Cardiovasc Surg 2006; 131: 1190-1.

  21. Farrar DJ, Holman WR, McBride LR, et al. Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. J Heart Lung Transplant 2002; 21: 516-21.

  22. Khatib R, Reyes MP, Smith F, Khatib G, Rezkalla S. Enhancement of coxsackie virus B4 virulence by indomethacin. J Lab Clin Med 1990; 116: 116-20.

  23. Rezkalla S, Khatib R, Khatib G, et al. Effect of indomethacin in the late phase of coxsackie virus myocarditis in a murine model. J Lab Clin Med 1988; 112: 118-21.

  24. Mason JW, O´Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, et al; Myocarditis Treatment Trial Investigators. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995; 333: 269-75.




2020     |     www.medigraphic.com